GlassScriptPhysician profile
Allison Koch
NPI 1639735624
$2,759.25
in general payments reported to CMS, 2019-2025
12 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $589 · 2022: $567 · 2023: $654 · 2024: $726 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $695.40 | 2021-2025 | Lifevest |
| Medtronic, INC. | $440.31 | 2022-2025 | Micra, Corevalve Evolut R, Linq II |
| Boston Scientific Corporation | $413.18 | 2021-2024 | Watchman Flx |
| Cvrx, INC. | $262.27 | 2022-2023 | Barostim Neo System |
| Abbott Laboratories | $206.75 | 2022-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $167.11 | 2023-2024 | |
| Amgen INC. | $132.69 | 2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $124.87 | 2021 | |
| Biotronik INC. | $112.12 | 2021 | |
| Astellas Pharma US INC | $103.20 | 2022 | |
| Abiomed | $85.06 | 2025 | |
| Merck Sharp & Dohme LLC | $16.29 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Koch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.